Topical cyclosporine A inhibits subepithelial immune infiltrates but also promotes viral shedding in experimental adenovirus models

Cornea

Volumn 24, Issue 1, 2005, Pages 86-91

  Romanowski, Eric G ^a,b   Pless, Patricia ^a   Yates, Kathleen A ^a   Gordon, Y Jerold ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b University of Pittsburgh School of Medicine   (United States)

Author keywords

Adenovirus; Cyclosporine A; Virus shedding

Indexed keywords

ARTIFICIAL TEAR; CORN OIL; CYCLOSPORIN A;

ADENOVIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; CORNEA; CORNEA DISEASE; DRUG EFFECT; DRUG POTENCY; EYE INFECTION; FEMALE; IMMUNE RESPONSE; IMMUNOMODULATION; IMMUNOPHARMACOLOGY; NONHUMAN; PRIORITY JOURNAL; RABBIT; SLIT LAMP; TEAR FILM; TREATMENT OUTCOME; VIRUS CULTURE; VIRUS EXCRETION; VIRUS INFECTION; VIRUS REPLICATION; VIRUS TITRATION;

ADENOVIRUS INFECTIONS, HUMAN; ADENOVIRUSES, HUMAN; ADMINISTRATION, TOPICAL; ANIMALS; CHEMOTAXIS, LEUKOCYTE; CYCLOSPORINE; DISEASE MODELS, ANIMAL; EPITHELIUM, CORNEAL; FEMALE; IMMUNOSUPPRESSIVE AGENTS; KERATOCONJUNCTIVITIS, INFECTIOUS; OPHTHALMIC SOLUTIONS; RABBITS; T-LYMPHOCYTES; VIRUS REPLICATION; VIRUS SHEDDING;

EID: 11144225752     PISSN: 02773740     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ico.0000127481.23714.b6     Document Type: Article

References (30)

1. Gordon Y, Aoki K, Kinchington PR. Adenovirus keratoconjunctivitis. In: Pepose JS, Holland GN, Wilhelmus KR, eds. Ocular Infection & Immunity. St Louis: Mosby, 1996:877-894.
2. Hillenkamp J, Reinhard T, Ross RS, et al. The effects of cidofovir 1% with and without cyclosporin a 1% as a topical treatment of acute adenoviral keratoconjunctivitis: a controlled clinical pilot study. Ophthalmology. 2002;109:845-850.
3. Kinchington PR, Araullo-Cruz T, Vergnes JP, et al. Sequence changes in the human adenovirus type 5 DNA polymerase associated with resistance to the broad spectrum antiviral cidofovir. Antiviral Res. 2002;56:73-84.
4. Romanowski EG, Roba LA, Wiley L, et al. The effects of corticosteroids of adenoviral replication. Arch Ophthalmol. 1996;114:581-585.
5. Romanowski EG, Yates KA, Gordon YJ. Topical corticosteroids of limited potency promote adenovirus replication in the Ad5/NZW rabbit ocular model. Cornea. 2002;21:289-291.
6. Romanowski EG, Yates KA, Gordon YJ. Short-term treatment with a potent topical corticosteroid of an acute ocular adenoviral infection in the New Zealand white rabbit. Cornea. 2001;20:657-660.
7. Kowalski RP, Foolks GN, Gordon YJ. Comparison of treatment regimens for ocular infections: community vs academic practice. Ann Ophthalmol. 2000;32:295-300.
8. Shiuey Y, Ambati BK, Adamis AP. A randomized, double-masked trial of topical ketorolac versus artificial tears for treatment of viral conjunctivitis. Ophthalmology. 2000;107:1512-1517.
9. Sail K, Stevenson OD, Mundorf TK, et al. Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease. CsA Phase 3 Study Group. Ophthalmology. 2000;107:631-639.
10. Williams DL. A comparative approach to topical cyclosporine therapy. Eye. 1997;11:453-464.
11. Cosar CB, Laibson PR, Cohen EJ, et al. Topical cyclosporine in pediatric keratoplasty. Eye Contact Lens. 2003;29:103-107.
12. Gordon YJ, Mokete M. Penetrating keratoplasty in children. J Pediatr Ophthalmol Strabismus. 1979;16:297-300.
13. Zhao JC, Jin XY. Immunological analysis and treatment of Mooren's ulcer with cyclosporin A applied topically. Cornea. 1993;12:481-488.
14. Hillenkamp J, Kersten A, Althaus C, et al. [Cyclosporin A therapy in severe anterior scleritis. 5 severe courses without verification of associated systemic disease treated with cyclosporin A]. Ophthalmologe. 2000; 97:863-869.
15. Reinhard T, Sundmacher R. Topical cyclosporin A in Thygeson's superficial punctate keratitis. Graefes Arch Clin Exp Ophthalmol. 1999;237: 109-112.
16. Kosrirukvongs P, Vichyanond P, Wongsawad W. Vernal keratoconjunctivitis in Thailand. Asian Pac J Allergy Immunol. 2003;21:25-30.
17. Pucci N, Novembre E, Cianferoni A, et al. Efficacy and safety of cyclosporine eyedrops in vernal keratoconjunctivitis. Ann Allergy Asthma Immunol. 2002;89:298-303.
18. Perry HD, Doshi-Carnevale S, Donnenfeld ED, et al. Topical cyclosporine A 0.5% as a possible new treatment for superior limbic keratoconjunctivitis. Ophthalmology. 2003;110:1578-1581.
19. Gunduz K, Ozdemir O. Topical cyclosporin as an adjunct to topical acyclovir treatment in herpetic stromal keratitis. Ophthalmic Res. 1997;29: 405-408.
20. Heiligenhaus A, Steuhl KP. Treatment of HSV-1 stromal keratitis with topical cyclosporin A: a pilot study. Graefes Arch Clin Exp Ophthalmol. 1999;237:435-438.
21. Perry HD, Doshi SJ, Donnenfeld ED, et al. Topical cyclosporin A in the management of therapeutic keratoplasty for mycotic keratitis. Cornea. 2002;21:161-163.
22. Shimura M, Yasuda K, Fuse N, et al. Effective treatment with topical cyclosporin A of a patient with Cogan syndrome. Ophthalmologica. 2000; 214:429-432.
23. Fujino Y, Joko S, Masuda K, et al. Ciclosporin microemulsion preconcentrate treatment of patients with Behcet's disease. Jpn J Ophthalmol. 1999;43:318-326.
24. Hingorani M, Calder VL, Buckley RJ, et al. The immunomodulatory effect of topical cyclosporin A in atopic keratoconjunctivitis. Invest Ophthalmol Vis Sci. 1999;40:392-399.
25. Kiang E, Tesavibul N, Yee R, et al. The use of topical cyclosporin A in ocular graft-versus-host-disease. Bone Marrow Transplant. 1998;22: 147-151.
26. Hillenkamp J, Reinhard T, Ross RS, et al. Topical treatment of acute adenoviral keratoconjunctivitis with 0.2% cidofovir and 1% cyclosporine: a controlled clinical pilot study. Arch Ophthalmol. 2001;119:1487-1491.
27. Reinhard T, Godehardt E, Pfahl HG, et al. [Local cyclosporin A in nummuli after keratoconjunctivitis epidemica. A pilot study]. Ophthalmologe. 2000;97:764-768.
28. Rivadeneira ED, Henshaw NG. Adenoviruses and adeno-associated viruses. In Joklik WK, Willet HL, Amos DB, Wilfert CM, eds. Zinsser Microbiology, 20th ed. Nowalk, CT: Appleton & Lange, 1992:969.
29. Gottsch JD, Akpek EK. Topical cyclosporin stimulates neovascularization in resolving sterile rheumatoid central corneal ulcers. Trans Am Ophthalmol Soc. 2000;98:81-87; discussion 87-90.
30. Perry HD, Donnenfeld ED, Acheampong A, et al. Topical cyclosporine A in the management of postkeratoplasty glaucoma and corticosteroid-induced ocular hypertension (CIOH) and the penetration of topical 0.5% cyclosporine A into the cornea and anterior chamber. CLAO J. 1998;24: 159-165.